Skip to content

Role of Ayurvedic Medicine In Liver Cancer.

Evaluation of Hepatoprotective Effect of Ayurvedic Medicine in Liver Cancer:A Single Arm Clinical Study

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/06/043136
Enrollment
10
Registered
2022-06-09
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K769- Liver disease, unspecified Health Condition 2: K768- Other specified diseases of liver

Interventions

None listed

Sponsors

National Institute of Ayurveda Jaipur
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. The patients between the age group of 30 to 70 years. 2. Known diagnosed cases of Liver cancer (primary & Secondary). 3. Patients willing to sign consent forms.

Exclusion criteria

Exclusion criteria: Patients suffering from any kind of major systemic illness such as, MI, IHD, Hypertension, renal failure, tuberculosis, bronchial asthma and Diabetes etc. Patients on radiotherapy and chemotherapy

Design outcomes

Primary

MeasureTime frame
Evaluation Of LFT and CBC (lab investigations)Timepoint: 30 days

Secondary

MeasureTime frame
Changes in Clinical Menifestation of Liver cancer. Quality Of Life Timepoint: 30 Days

Countries

India

Contacts

Public ContactDr Nitin Agrawal

National Institute of Ayurveda Jaipur

drnkagarwal85@gmail.com9694957694

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026